The global market for catheter stabilization devices — a medical innovation that ensures the secure attachment of various catheter types to the patient’s body, minimizing unwanted movements and preventing accidental dislodgment — was worth $1.6 billion in 2024. Current forecasts anticipate consistent growth, marking a Compound Annual Growth Rate (CAGR) of 7% from 2025 through to 2034. This continual development is predominantly triggered by the rise of acute conditions that require catheter use, such as end-stage kidney failure, cardiovascular diseases, cancer, and diabetes.
The degenerative health pathologies, as indicated by a 2024 World Health Organization report, contribute significantly towards the necessity for devices that enhance catheter stability, mainly for extended hospital stays and recurring outpatient treatments. Venturing into specific condition, cardiovascular diseases emerged as the leading cause for non-communicable disease deaths in 2021, accounting for approximately 19 million fatalities. Following this, cancer caused 10 million deaths, chronic respiratory diseases resulted in 4 million deaths, while diabetes and kidney disease-related deaths amassed over 2 million fatalities.
Primarily because of these chronic ailments, the demand for catheter stabilization devices soars, with a focus on minimizing the complications, fortifying catheter safety, and augmenting overall patient safety. An aging population, prone to chronic diseases, routinely requires invasive medical procedures like urinary catheterization, dialysis, and IV therapy. This situation drives the demand for superior quality catheter stabilization devices, especially considering the elderly’s delicate skin that necessitates enhanced catheter stabilization for optimal treatment safety and comfort, thus prompting considerable market growth.
Hospitals, as part of their stringent infection management strategies, are reducing catheter-associated infections like CAUTIs and CLABSIs. An effective measure in achieving this has been the integration of catheter stabilization devices into regular infection prevention protocols, consequently contributing to the market’s positive growth curve. Diving into segments, in terms of product, the market is bifurcated into central venous catheter securement devices, arterial securement devices, peripheral securement devices, urinary catheters securement devices, chest drainage tubes securement devices, and others.
In 2024, the central venous catheter securement devices segment had the lion’s share of the revenue, at 32.7%. In relation to the application, the market includes cardiovascular procedures, general surgery, urological procedures, oncology procedures, among others. Here, the general surgery segment reigned supreme, bringing in revenue of $553.5 million in 2024, with an expected substantial CAGR during the forecast period.
In terms of end use, the market includes hospitals, ambulatory surgical centers, home care settings, and others, with hospitals accounting for the largest revenue share of 53.9% in 2024. From a regional perspective, North America led in 2024 with a total value of $731.5 million and a predicted CAGR of 6.9% thanks to rigorous infection control regulations and an escalating aging population. By 2034, the U.S. market is projected to reach $1.3 billion, up from $667.5 million in 2024.
Europe follows closely, and Asia Pacific exhibits the fastest growth. Also noteworthy is the market expansion happening in Saudi Arabia, Brazil, Japan and the UK. Competition in the market landscape features both local and global players working to meet the rising demand for advanced devices among a growing patient base.
Top companies like 3M, BD, B. Braun, ConvaTec, and Cardinal Health jointly control about 65% of the market share. The presence of emerging technologies and concentration on delivering customized solutions heavily influences this competition. Multi-national firms deal with having to balance affordability and high-quality in nations where cost is a decisive factor. Local manufacturers thrive in such situations by delivering economically viable alternatives, causing big firms to adapt their pricing structures whilst maintaining product durability, safety, and adherence to required standards.
Source: https://www.gminsights.com/industry-analysis/catheter-stabilization-devices-market